Article Details
Retrieved on: 2025-03-20 07:09:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 5,631,321 shares of the biopharmaceutical company's stock worth $185,045,000 after buying an additional 85,339 shares ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here